![]() Receipt of any drug as part of a research study within 30 days before screening.Patients or guardians of patients, who are unable or unwilling to give informed consent or assent respectively.Patients whose close personal contacts will not or are not willing to comply with standard of care for Scabies management.Patients who, in the opinion of the Investigator, would be non-compliant with the requirements of the study protocol.Family members of employees of the clinic or Investigator.Women who are pregnant, planning pregnancy or lactating.Any condition, medical, psychological, or social, that, in the Investigator's opinion, would interfere with participation in the study.Patients with an underlying immunodeficient state (including prolonged treatment with corticosteroids), immunosuppressive disorders requiring therapy, severe systemic disease and history of HIV infection.Patients with crusted/Norwegian scabies.Use of any systemic or topical acaricide 1 month before enrollment.Known hypersensitivity to permethrin cream or any of its components, ragweed or chrysanthemums, synthetic pyrethroids or pyrethrin.If patient is a child, then parent/guardian will apply study product to him/her. Ability to apply study product to self or to other person if a child.Free from any systemic or dermatologic disorder that, in the opinion of the Investigator, will interfere with the study results or increase the risk of adverse events.Agree to use a medically accepted form of birth control (oral, implant, injectable or transdermal contraceptives, intrauterine device, condom plus spermicide, diaphragm plus spermicide) or practice abstinence throughout the study period.Have a negative urine pregnancy test result upon entry into the study.Had a normal menstrual cycle for the month before start of treatment.Have been using systemic birth control, intrauterine device, or used barrier methods such as diaphragm plus spermicide or condom plus spermicide consistently, at least 14 days before study cream administration.Women must be either 1 year post-menopausal (no menstrual periods for at least 12 months), surgically sterile, or if they are of child-bearing potential, they must: Symptom score of 2 or 3 on a 4-point rating scale of 0-3 for nocturnal itching.Parasitological confirmation of clinical diagnosis with demonstration under light microscope of mites and/or their products (larvae, eggs or fecal material).Diagnosis of active scabies by presence of a burrow and/or typical scabietic lesions at the classic sites of infestation.Male or non-pregnant, non-lactating female at least 2 years of age or older.Signed Informed Consent that meets all criteria of current FDA regulations.Why Should I Register and Submit Results?.The treatment of scabies: A systematic review of randomized controlled trials. You can learn more about how we ensure our content is accurate and current by reading our editorial policy. We link primary sources - including studies, scientific references, and statistics - within each article and also list them in the resources section at the bottom of our articles. Medical News Today has strict sourcing guidelines and draws only from peer-reviewed studies, academic research institutions, and medical journals and associations.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |